SCHEMBL6561553

SCHEMBL6561553

CCCc1c(O)ccc2c1OCC2=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PSMB5 P28074 1/20 0.58
▸ LTB4R Q15722 7/20 0.41
▸ LTB4R2 Q9NPC1 7/20 0.41
▸ ESR1 P03372 2/20 0.40
▸ ESR2 Q92731 2/20 0.40
▸ PARP1 P09874 1/20 0.39
▸ PTPN1 P18031 1/20 0.36
▸ CYP1A1 P04798 1/20 0.36
▸ CYP1B1 Q16678 1/20 0.36
▸ SLC22A12 Q96S37 3/20 0.36
▸ SLC2A9 Q9NRM0 2/20 0.36
▸ XDH P47989 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ MITF O75030 1/20 0.35
▸ ALPL P05186 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ ALPI P09923 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9120331 0.85 LTB4R (0.56) PSMB5LTB4RLTB4R2ESR1ESR2
SCHEMBL30251527 0.85 LTB4R (0.56) PSMB5LTB4RLTB4R2ESR1ESR2
SCHEMBL9122046 0.76 ESR1 (0.36) PSMB5LTB4RLTB4R2ESR1ESR2
SCHEMBL9121287 0.76 LTB4R (0.50) LTB4RLTB4R2ESR1ESR2
SCHEMBL1429217 0.75 PSMB5 (0.68) PSMB5ESR1ESR2PARP1KDM4E
SCHEMBL14735532 0.75 KDM4E (0.54) PSMB5KDM4EMEN1POLBGAA
SCHEMBL6611223 0.74 PSMB5 (1.00) PSMB5ESR1ESR2PARP1KDM4E
SCHEMBL14883890 0.74 PSMB5 (0.53) PSMB5KDM4EMEN1POLBGAA
SCHEMBL14883923 0.74 PSMB5 (0.53) PSMB5KDM4EMEN1POLBGAA
SCHEMBL18883724 0.74 PSMB5 (0.53) PSMB5PARP1PTPN1CYP1A1CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0904079-B1 ANTIDIABETIC AGENTS MERCK & CO INC (US) 2004-03-24 — — EP disclosed
EP-0904079-A4 — — 1999-05-06 — — EP disclosed
EP-0904079-A1 ANTIDIABETIC AGENTS Merck & Co., Inc. (US) 1999-03-31 — — EP disclosed
US-5859051-A ACETYLPHENOL DERIVATIVES MERCK & CO., INC. (US) 1999-01-12 — — US disclosed
WO-1997027857-A1 ANTIDIABETIC AGENTS MERCK & CO., INC. (US) 1997-08-07 — — WO disclosed
US-5434186-A Antiinflammatory agents HOFFMANN-LA ROCHE INC. (US) 1995-07-18 — — US disclosed
US-5273999-A A 4-keto-boroalkyleneoxychroman or 2,3-dihydrobenzofuran derivative HOFFMANN-LA ROCHE INC. (US) 1993-12-28 — — US disclosed
EP-0531823-A1 Bicyclic carboxylic acid derivatives as anti-inflammatory agents F. HOFFMANN-LA ROCHE AG (CH) 1993-03-17 — — EP disclosed
Send feedback